Newamsterdam Pharma Co N.v.
NAMS
Revenue
12.77M
▼-16.34M▼-56.13%
3 Months ChangeAssets
471.10M
▼-60.49M▼-11.38%
6 Months ChangeLiabilities
107.12M
▲46.79M▲77.56%
3 Months ChangeFree Cash Flow
-54.99M
▼-23.12M▼-72.54%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-18
Form 8-K
ID: 0001193125-24-239687
2024-08-09
Form 8-K
ID: 0001193125-24-197971
2024-08-07
Form 10-Q
ID: 0000950170-24-092281
2024-08-07
Form 8-K
ID: 0000950170-24-092279
2024-07-29
Form 8-K
ID: 0001193125-24-186747
2024-07-18
Form 8-K
ID: 0001193125-24-180754
2024-06-11
Form 8-K
ID: 0001193125-24-158751
2024-06-07
Form 8-K
ID: 0001193125-24-157374
2024-05-09
Form 8-K
ID: 0000950170-24-056292
2024-05-08
Form 10-Q
ID: 0000950170-24-055767